Klusmann JH. J Clin Oncol. 2018 Apr 1;36(10):1007-1016. doi: 10.1200/JCO.2017.75.2204. EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via
Ohkura, R., Shimada, T., Manstein, D.J., and Sutoh, K. (2006). Functional characterization of the N-terminal region of myosin-2. J Biol Chem 281 , 36102-36109. (Abstract)(pdf) Fedorov, R., Witte, G., Urbanke
Gotina L, Lim S, Jahreis K, Vollbrecht AL, Kim YK, Pae AN, Labus J, Ponimaskin E. Structural determinants for activation of the Tau kinase CDK5 by the serotonin receptor 5-HT7R. Cell Commun Signal. 2024 [...] Mikesh M, Smith I, Nave KA, Schwab MH, Thompson WJ. Neuregulin1 displayed on motor axons regulates terminal Schwann cell-mediated synapse elimination at developing neuromuscular junctions. Proc Natl Acad
Burkhard. Environmental Microbiology. 2022. Publisher's page Bacterial low-abundant taxa are key determinants of a healthy airway metagenome in the early years of human life Pust, Marie-Madlen; Tümmler, Burkhard [...] 1186/1471-2121-14-51. Publisher's page EU FP7 funded COST Action BM1003 "Cell surface virulence determinants of cystic fibrosis pathogens". Developing an international Pseudomonas aeruginosa reference panel [...] H, Moreno R, Maine GN, Kracht M, Schmitz ML, Burstein E. Oncogene. 2011; Publisher's page c-Jun N-terminal kinase phosphorylates DCP1a to control formation of P bodies. Rzeczkowski K, Beuerlein K, Müller
Liu, Xiaofei, Norbert Benda, Clemens Mittmann, and Armin Koch . 2024. “Combining Recurrent and Terminal Events Into a Composite Endpoint May Be Problematic.” Statistics in Biopharmaceutical Research 1–8 [...] Grosse. 2023. “Diagnostic Value of Carotid Intima-Media Thickness and Clinical Risk Scores in Determining Etiology of Ischemic Stroke.” European Stroke Journal 8(3):738–46. doi: 10.1177/23969873231182492 [...] 1002/sim.6473. Budde, S., Y. Noll, V. Zieglschmid, C. Schroeder, A. Koch , and H. Windhagen. 2015. “Determination of the Efficacy of EVICELTM on Blood Loss in Orthopaedic Surgery after Total Knee Replacement:
Schwerpunkt: Onkologie und OP / Hauttumorzentrum Leitung Hauttumorzentrum Ärztliche Bereichsleitung Dermatoonkologie: Prof.'in Dr. med. Imke von Wasielewski Oberärztin, Stellvertretende Leitung Dermat